Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2010
11/02/2010US7824874 Method for measuring in vivo mutation frequency at an endogenous gene locus
11/02/2010US7824661 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/02/2010CA2452531C Insulating and functionalizing fine metal-containing particles with conformal ultra-thin films
10/2010
10/28/2010WO2010124257A2 Methods and kits for determining oxygen free radical (ofr) levels in animal and human tissues as a prognostic marker for cancer and other pathophysiologies
10/28/2010WO2010123918A1 Encapsulation of microbubbles within the aqueous core of microcapsules
10/28/2010WO2009109798A3 Precursors of lipid metabolism for the diagnosis and treatment of cancer
10/28/2010WO2008128051A3 Fluorescent nanoparticle compositions, methods and devices
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272653 Contrast Medium for Use in Imaging Methods
10/28/2010US20100272651 Method for assessing potential for tumor development and metastasis
10/28/2010US20100272649 Bioactive Bone Cement and Method for Its Production
10/28/2010US20100272648 Methods of Identifying Improved NMDA Receptor Antagonists
10/28/2010US20100272646 Method for inducing lymphoid tissue and modulating intestinal homeostasis
10/28/2010US20100272645 Myocardial perfusion imaging method
10/28/2010US20100272644 Complexation of fatty acid-conjugated molecules with albumin
10/28/2010US20100272643 Procaspase 8-Mediated Disease Targeting
10/28/2010US20100272640 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010US20100272638 Radiolabelled microparticles, processes for the preparation thereof and the use thereof
10/28/2010US20100272635 Methods and compositions for diagnosis and/or prognosis in ovarian cancer and lung cancer
10/27/2010EP2243496A2 Contrast agents to target extracellular matrix
10/27/2010EP2242515A2 Process for preparing a pharmaceutical formulation of contrast agents
10/27/2010EP1830879B1 Mri guided photodynamic therapy for cancer
10/27/2010EP1658282B1 Novel chelating agents and chelates and their use
10/27/2010EP1601970B1 Detection, monitoring and treatment of cancer
10/27/2010CN101869716A System for monitoring bacterial tumor treatment
10/27/2010CN101366953B Small numerator modified iron oxide nano-granule freeze-dried powder for injection and preparation method thereof
10/26/2010USRE41884 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
10/26/2010US7820621 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
10/26/2010US7820444 Administering labeled conjugated isoprenoids, lipids, saccharides, polyols or polyethylene glycols to mammals and monitoring presence in bodily fluids; forensic detection of coded compounds in mammals; drug abuse and dependence; drug screening
10/26/2010US7820208 instructing group of individuals to combine primarily salty tastant with primarily salty foods and primarily sweet tastant with primarily sweet foods and after testing period ends, determining whether the individuals of the group lost weight during the testing period
10/26/2010US7820184 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820142 detecting a M. tuberculosis Apa protein-specific CD4+ T lymphocyte response; detected CD4+ T lymphocyte response is indicative of tuberculosis in said patient and differentiates tuberculosis from an immunization with BCG (Bacillus Calmette-Guerin)
10/26/2010CA2373250C Measuring caspase 3 activity to determine viral stability
10/26/2010CA2291138C Transplants for myocardial scars and method and cellular preparations therefor
10/21/2010WO2010121133A2 Multimodal imaging of fibrin
10/21/2010WO2010121003A1 Pyrazine derivatives for optical imaging and therapy
10/21/2010WO2010120905A2 Novel nano-probes for molecular imaging and targeted therapy of diseases
10/21/2010WO2010120849A2 Synthesis of silicon nanorods
10/21/2010WO2010119583A1 Polymer-nucleic acid complex, method for imaging tumor cells or the like using same, and pharmaceutical composition for treatment of cancer
10/21/2010WO2010119362A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
10/21/2010WO2010118521A1 Peptide ligands for clusterin and uses thereof
10/21/2010WO2010099137A3 In situ methods for monitoring the emt status of tumor cells in vivo
10/21/2010WO2010093635A3 Systems and methods for measuring and modeling in vivo manganese ion transport in a subject
10/21/2010WO2010083154A3 Heterofunctional segment-poly(ethylene glycol) polymers as delivery vehicles
10/21/2010WO2010051530A3 Compositions and methods for delivering a substance to a biological target
10/21/2010WO2009111273A3 Peptide targeting imaging agents and methods of use thereof
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266508 Stabilized gold nanoparticle and contrast agent
10/21/2010US20100266507 Luminescent compounds
10/21/2010US20100266506 Flourescent Dendrimer Compounds and Use of Such Compounds in Multi-Photon Devices or Processes
10/21/2010US20100266505 Immunotherapy regimes dependent on apoe status
10/21/2010US20100266504 Condensed pyridine derivative and use thereof
10/21/2010US20100266503 Breast Cancer Methods, Medicaments and Agents
10/21/2010US20100266502 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
10/21/2010US20100266501 Methods and compositions for organ protection
10/21/2010US20100266500 Stilbene derivatives and their use for binding and imaging amyloid plaques
10/21/2010US20100266495 Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/21/2010US20100266491 System for targeted delivery of therapeutic agents
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010CA2756570A1 Peptide ligands for clusterin and uses thereof
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241394A1 Gold nanoparticle composition, dna chip, near infrared absorbent, drug carrier for drug delivery system (dds), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use
10/20/2010EP2241335A1 Method and system for determining whether a drug will be effective on a patient with a disease
10/20/2010EP2240206A1 N-alkoxyamide conjugates as imaging agents
10/20/2010EP2240205A1 Telemetry through remote detection of nmr-active particles
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010CN101863788A 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof
10/20/2010CN101862461A Gadolinium-containing macromolecular contrast agent for specific imaging of lymphatic system and preparation method thereof
10/20/2010CN101862460A Sterilizing medicinal ultrasonic coupling agent and preparation method thereof
10/20/2010CN101148511B Method for preparing fluorescent chitosan micro-sphere and application of the same in tracer field
10/20/2010CN101028524B Supersonic microvesicle target positioning controlled-release/gene device and target transferring method
10/19/2010US7817824 Unified system and method for animal behavior characterization from top view using video analysis
10/19/2010US7816149 comprises a selectively coated quantum dot having selected band gap energies, characteristic absorption, emission spectra and outer coatings for therapy and diagnostic purposes in biophotonics and nanomedicine
10/19/2010US7816074 α4 β2 δGABA-A receptors as a strategy for PMS and alcoholism
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010US7815896 Type III secretion pathway in Aeromonas salmonicida and uses therefor
10/19/2010US7815895 screening for substance that excites afferent vagal nerve from the liver, wherein substance is comprised in culture supernatant of hepatocyte in which Peroxisome proliferator activated receptor gamma 2 is overexpressed, then examining if substance suppresses weight gain or obesity
10/19/2010US7815894 Diagnosis of Alzheimer's disease; binding to a glycerophosphocholine compound
10/14/2010WO2010118034A2 Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells
10/14/2010WO2010116550A1 Method for testing sensitivity of tumor tissue
10/14/2010WO2010116209A1 Fucoidans as ligands for the diagnosis of degenerative pathologies
10/14/2010WO2010116185A1 Insulin stabilized nanoparticles
10/14/2010WO2010068705A3 Encapsulated agent guided imaging and therapies
10/14/2010WO2010063483A3 Active ingredient-peptide construct for extracellular enrichment
10/14/2010US20100263064 Animal model for chronic obstructive pulmonary disease and cystic fibrosis
10/14/2010US20100263063 Mouse models with enhanced essential tremor and preparation method thereof
10/14/2010US20100263062 Methods for screening and compounds that protect against amyloid diseases
10/14/2010US20100263061 Properdin Modulation of Alternative Pathway and Uses Thereof
10/14/2010US20100261946 Flexible and/or elastic brachytherapy seed or strand
10/14/2010US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261167 In vivo screen using chemical inducers of dimerization
10/14/2010US20100260834 Abuse-deterrent drug formulations
10/14/2010US20100260833 Abuse-proofed dosage form
10/14/2010US20100260686 Nanoparticles for brain tumor imaging
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 354